ONCAlert | Upfront Therapy for mRCC

Case Studies: Lung Cancer

Expert physicians provide insight on managing oncology-based patient cases that highlight the use of novel agents in clinical practice.

SORT BY: A-Z Recent

VIEW AS: Grid List

A 62-Year-Old Woman With Metastatic BRAF V600E-Mutated NSCLC

A 63-Year-Old Woman With Metastatic EGFR-Mutated Non-Small Cell Lung Cancer

A 60-Year Old Man With Untreated Stage IV EGFR-Mutated Non-Small Cell Lung Cancer

A 62-Year-Old Male With Stage III Non-Small Cell Lung Cancer

A 64-Year-Old Male with Untreated Stage IV EGFR-Mutated NSCLC

Improving Overall Survival In Extensive Stage Small Cell Lung Cancer

Relapsed ALK-Rearranged NSCLC

A 61-Year-Old Man With ALK-Rearranged NSCLC

Stage IIIB Unresectable NSCLC After Chemoradiotherapy

Stage IIIA Unresectable NSCLC After Chemoradiotherapy

A Chemoimmunotherapeutic Approach to Nondriver NSCLC

Considering Triplet Therapy for Nondriver NSCLC

Managing Metastatic NSCLC With Rapid Progression

Clinical Management of NSCLC With Bone Metastases

Treatment Regimen for Patients With ALK+ Non-Small Cell Lung Cancer

A 50-Year-Old Woman With ALK-Rearranged NSCLC

Considerations for Treating Locally Advanced NSCLC

Consolidation Therapy for Locally Advanced NSCLC

Treatment Considerations for Unresectable Locally Advanced NSCLC

Frontline Treatment Strategies in EGFR-Mutant NSCLC

Clinical Approach for Unresectable Locally Advanced NSCLC

EGFR-Mutant Non-Small Cell Lung Cancer With Brain Metastases

Non-Driver NSCLC: Practice Considerations

Clinical Decisions in Non-Driver NSCLC

Treatment of NSCLC With Uncommon EGFR Mutations

NonDriver Metastatic Lung Large Cell Carcinoma

A Case of Metastatic ALK-Rearranged Non-Small Cell Lung Cancer

ALK-Translocated Non-Small Cell Lung Cancer With Bone Metastases

Treatment of BRAF Mutated Non-Small Cell Lung Cancer

Treatment of ALK+ Non-Small Cell Lung Cancer

Treatment of EGFR Mutant Non-Small Cell Lung Cancer

NSCLC with Multiple Sites of Metastasis and No Driver Mutation

Metastatic Lung Adenocarcinoma Without a Driver Mutation

Advanced Squamous Non-Small Cell Lung Cancer

Nuances in Treating Squamous Cell Lung Cancer

Metastatic Non-Small Cell Lung Cancer with Alexander Drilon, MD

EGFR Testing for Metastatic Non-Small Cell Lung Cancer with Jonathan W. Riess, MD, MS

Metastatic Lung Cancer with Jared M. Weiss, MD

mNSCLC with Mark Kris, MD and Mark Socinski, MD

Molecular Diagnostics in NSCLC with David Berz, MD, PhD, and Philip Bonomi, MD

Metastatic NSCLC with Corey J. Langer, MD, David Spigel, MD, Denise O'Dea, NP, and Jack West, MD

Publications

Copyright © TargetedOnc 2020 Intellisphere, LLC. All Rights Reserved.